ContentslistsavailableatScienceDirect
Neuroscience
Letters
j o ur na l h o me p a g e :w w w . e l s e v i e r . c o m / l o c a t e / n e u l e t
Hippocampal
ether-à-go-go1
potassium
channels
blockade:
Effects
in
the
startle
reflex
and
prepulse
inhibition
A.C.
Issy
a,1,
J.R.
Fonseca
b,1,
L.A.
Pardo
c,
W.
Stühmer
c,
E.A.
Del
Bel
a,∗aDepartmentofMorphologyPhysiologyandBasicPathology,UniversityofSãoPaulo(USP),DentalSchoolofRibeirãoPreto,Brazil bFederalUniversityofSãoPaulo(UNIFESP),Brazil
cDepartmentofMolecularBiologyofNeuronalSignals,Max-PlanckInstituteofExperimentalMedicine,Gottingen,Germany
h
i
g
h
l
i
g
h
t
s
•Eag1K+channelsblockadeinthedentategyrusofthehippocampusdidnotmodifyapomorphine-disruptiveeffectsinthePPI.
•DentategyrussurgeryinducingdecreasedstartleresponsewasrestoredbytheEag1antibody. •TheroleofEag1K+channelsinthestartleresponsemeritsfurtherinvestigation.
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received6August2013 Receivedinrevisedform 13November2013 Accepted16November2013
Keywords:
Dopamine Prepulseinhibition Schizophrenia Eag1 Kv10.1 Startlereflex
a
b
s
t
r
a
c
t
Recently,ourgroupdescribedtheether-à-go-go1(Eag1)voltage-gatedpotassium(K+)channel(Kv10.1) expressioninthedopaminergiccellsindicatingthatthesechannelsarepartofthediversifiedgroupofion channelsrelatedtodopaminergicneuronsfunction.Theincreaseofdopamineneurotransmissioninduces areductionintheprepulseinhibition(PPI)oftheacousticstartlereflexinrodents,whichisareliable indexofsensorimotorgatingdeficits.ThePPIresponsehasbeenreportedtobeabnormallyreducedin schizophreniapatients.TheroleofEag1K+channelsinthePPIreactionhadnotbeenrevealeduntilnow, albeitthesingulardistributionofEag1inthedentategyrusofthehippocampusandthehippocampal regulationofthestartlereflexandPPI.TheaimofthisworkwastoinvestigateifEag1blockadeon hippocampusmodifiesthePPI-disruptiveeffectsofapomorphineinWistarrats.Bilateralinjectionof anti-Eag1single-chainantibodyintothedentategyrusofhippocampusdidnotmodify apomorphine-disruptiveeffectsinthePPIresponse.However,Eag1antibodycompletelyrestoredthestartleamplitude decreaserevealedafterdentategyrussurgery.Thesepotentiallybiologicalimportantphenomenonmerits furtherinvestigationregardingtheroleofEag1K+channels,mainly,onstartlereflexmodulation,since thephysiologicalroleofthesechannelsremainobscure.
© 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Ether-à-go-go-related gene (ERG) potassium (K+) channel is
mainlyexpressedinthehumanandrodentsadultbrain[23,24].
ERGK+channelsbelongtoasuperfamilyofvoltage-activatedK+
channelsencoded by three distinct gene subfamilies, including
ether-à-go-go (eag), ether-à-go-go-like (elk), and ether-à-go-go -related(erg)genes[8,42].Amongthem,theEagK+channelappears
tobetheonlymainlyneuron-specificand localizedtosynapses
∗Correspondingauthorat: DepartmentofMorphologyPhysiologyandBasic Pathology,UniversityofSãoPaulo,DentalSchoolofRibeirãoPreto,Centerfor Inter-disciplinaryResearchonAppliedNeurosciences(NAPNA),14049-904,Brazil. Tel.:+551636024047;fax:+551636330999.
E-mailaddress:eadelbel@forp.usp.br(E.A.DelBel).
1 Theseauthorscontributedequallytothiswork.
[18]. Eag K+ channel is representedby the Eag1 gene (KCNH1,
Kv10.1)[26,42]andEag2 (KCNH5,Kv10.2)[19,23].HighestEag1
geneexpressionisfoundinthecerebralcortex,hippocampus, cere-bellumandhypothalamusofhumanandrat,whichgreatlyoverlaps withEag1proteinexpression[24].However,thefunctionofEag1 K+channelsinthecentralnervoussystemisstillunknown[26,27].
ItwassuggestedthatthelateraldiffusionofEag1ionchannelsacts
asadynamicalmechanismtoaccruethesechannelstothe
synap-ticterminals,wheretheyshouldplaya pivotalroleforsynaptic functionandplasticity[11].TheexpressionoftheEag1K+channel
ishighinthenigrostriatalpathwayanditisco-localizedwiththe dopaminergiccells[7].Thisdatasuggeststhatthesechannelsmay wellparticipateinthephysiologyofthedopaminergicsystem[7]. Sensorimotorgatingistheabilitytogateoutirrelevantstimuli, anormalcentralinhibitoryprocessesexpression,anditsabilitycan beaccessedthroughprepulseinhibition(PPI)inhumans[2,29,38]
and rodents [3,36,37]. Schizophrenia patients exhibit heritable
0304-3940/$–seefrontmatter© 2013 Elsevier Ireland Ltd. All rights reserved.
postmortemhistological,morphometricandgeneticanalyses[14]. SpecificevidenceforthehippocampalregulationofPPIcomesfrom experimentalanimal studies [5,39]. Recently, K+ channels have
beenproposedtoplayaroleinthemechanismsofneuralplasticity whicharealteredinvariouspsychiatricdisorders,especiallyin hip-pocampus[16].Thedentategyrusofthehippocampusactsasthe “gatekeeper”orthe“filter”ofthehippocampalfunction[10].Ithas
beendescribedthatdopaminemodulatestheactivityofnew
den-tategranulecellsinthedentategyrus[25].Also,dopamineactsas agateonthedirectcorticalinputtothehippocampus,modulating synapticplasticityandinformationflowinafrequency-dependent manner[17].In thiscontext,Eag1K+ channelexpressioninthe
dentategyrusofhippocampalneurons[7]becomesinteresting. Becauseof thelack ofspecific pharmacologicalinstruments,
Eag1monoclonalantibodymayprovideanattractivetoolto
elu-cidatethe functional role of this channel in mammalian brain
[24].Monoclonalantibodiesrepresentastrategytogeneratehighly selectiveinhibitorsagainstcellsurfacemolecules,enablinga spe-cificantigentobedistinguishedfromitsclosehomologues[12,31]. AspecificEag1antibodywasvalidatedanddescribedasthefirst monoclonalantibodythatselectivelyinhibitsaK+currentinintact
cells[12].Takingadvantageofthespecificityoftherecombinant anti-Eag1single-chainantibody,andthesingulardistributionof Eag1inthehippocampus(Fig.1)[7]weinvestigatetheeffectsof Eag1antibodymicroinjectionintothedentategyrusofratsafter
systemicapomorphinetreatment.
2. Materialsandmethods
2.1. Animals
Male Wistarrats (n=11; 250–300g) were used. The
experi-mentalprotocolfollowedtheguidelinesforthecareanduseof
mammalsinNeuroscienceand BehavioralResearch(ILAR, USA).
Rats werehoused fourper cage, undercontrolled temperature
(23±1◦C)andlight/darkcycle(12–12h;lightsonat0600hours)
withfoodandwaterconstantlyavailable.Testswereperformedin thelightphase.
2.2. Drugs
Apomorphine(Sigma–Aldrich,Germany)wasdissolvedin
dis-tilledwaterwith0.1%ascorbicacidandinjectedsubcutaneously (s.c.;0.5mg/kg)at 1ml/kg.Eag1-specific recombinantanti-Eag1 single-chainantibody(1g/1lofwaterRNAsefree)was
bilat-erallyinjectedwith30 gaugeneedles(16mm)intothedentate
gyrusatavolumeof0.5Ldeliveredover60susingamicrodrive
injectionpump.
test(post-surgicalanalyses)beforeapomorphinetreatment.
2.4. Surgery
Rats were anesthetized with ketamine/xylazine (10:7,
100mg/kg; intraperitoneal) and placed in a stereotaxic
appa-ratus.Stainless steel guidecannulaewere bilaterallyimplanted
3mmabovetheinjectionsitewithinthedentategyrus
(antero-posterior,−4mm;lateral,±2.6mm;dorso-ventral,−2.1mm)[28].
Theguidecannulaewerekeptunobstructedbydummystylets.
2.5. Experimentaldesign
Aftersurgeryforbilaterallyhippocampuscannulae implanta-tionallratsshowedasignificantdecreaseoftheirstartleamplitude (comparedtopre-testcondition).Animalsweretestedrepeatedly (pre-test,post-surgicalapomorphine,andapomorphine+Eag1K+
channelantibody)withaminimumintervalof4days,with excep-tionofthepostsurgicaltest.PPIdisruptionwasinducedbyacute apomorphinetreatment.Microinjectionoftheanti-Eag1K+
chan-nelantibodybilaterallyinthedentategyrusofhippocampuswas
conducted20minaftertheapomorphinetreatment.Tworatswere
notincludedinthebehavioralanalyses(Fig.2).
2.6. Statisticalanalyses
The acoustic startle response to pulse alone and to
pre-pulse+pulse was analyzed by repeated measures analysis of
variance(RM-ANOVA)withstimuli(fourlevels:pulse;81 or73
or69dBprepulse+pulse)asawithin-subjectsfactorandcondition (preorpost-surgicalorpharmacologicaltreatment;fourlevels)as
between-subjectsfactors.Forthemean%PPI,RM-ANOVAwas
con-ductedwithintensityofprepulse(threelevels)asawithin-subject factor,andconditionasabetween-subjectsfactor.Inthecaseof
significantmaineffectstheRM-ANOVAwasfollowedbyDuncan’s
testforposthoccomparisons(P<0.05).
3. Results
3.1. Startleamplitude
Wefoundasignificantmaineffectofstimuli(F(3,96)=13.017;
P=0.000)andcondition(F(3,32)=6.48;P=0.001),butnota signif-icantinteractionbetweenstimuliand condition(F(9,96)=1.866;
Fig.1. PhotomicrographsAandBshowingEag1immunoreactivityintherathippocampus.Thedetectionsystem(NBT/BCIP)producedanintensebluecolormainlyinthe cellbodies.
thestartleamplitude wassignificantlyincreased (bringto nor-mal)comparedwiththepost-surgicalcondition(posthocDuncan;
P<0.05;Fig.3).Inthe81and73dBprepulse+pulsetrialsthestartle
magnitudewassignificantlowerthantherespectivestimulusof
thepre-testcondition.However,importantly,thestartle
ampli-tudetothe pulsewashigherthan thestartleamplitudetothe
prepulse+pulse(withallprepulseintensities)inthepostsurgical condition(Fig.3).
3.2. Prepulseinhibition
There was a significant effect of condition (F(3,32)=4.10;
P=0.014),butnotofprepulseintensity(F(2,64)=0.185;P=0.831)
or an interaction between prepulse intensity and condition
Fig. 2.Hematoxilin-eosin representative histological sectionand cannulae-tip placementsschemawithinthedentategyrusofhippocampus.Injectionneedletips locationwithinthedentategyrusofhippocampuswasdeterminedaccordingtothe standardizedplates–Bregma−2.06;interaural1.74mm[28].Twoanimalswithin cannulaeinsertionsoutsidethedentategyruswerenotincludedindataanalyses.
(F(6,64)=1.105;P=0.369).Systemictreatmentwithapomorphine inducedsignificantPPIdisruption.Eag1antibodyinjected bilat-erallyintothedentategyrusdidnotmodifythiseffect(posthoc Duncan;P<0.05;Fig.4).PPIonpost-surgical conditionwasnot differenttothepre-test(datanotshown).
4. Discussion
DopaminesystemappearstobecriticalconnectedtothePPI
modulation[36].PPIresponsemaybedisruptedinschizophrenia patients[2,36],despitethefactthatPPIimpairmentisobservedin severalotherpsychiatricdisorders[2,9].Clearly,thePPIdeficitthat isexperimentallyinduceddoesnotconstituteananimalmodelof schizophreniapersebutappearstoprovideanapplicablemodelof sensorimotorgatingdeficit[9,25].Theantipsychoticdrugsusedto
treatschizophreniasymptomssharethepharmacologicalproperty
ofdopamineD2receptorantagonism[20].Itwassuggested, how-ever,thatthetherapeuticactionofantipsychoticdrugscouldbein additiondependentonthepresynapticERGK+channelinhibition
[6,32,40].WeinvestigatetheabilityofanEag1K+channelantibody
microinjectedintothedentategyrusofhippocampusto
attenu-atetheapomorphine-inducedPPIdisruption.Bilateralinjectionof
Fig.3.EffectsofEag1K+channelsantibodyonthestartleamplitude.Animals
showedsignificantdecreaseintheirstartleamplitudetopulsealoneaftersurgery. Apomorphinetreatmentinducedanincreaseinthestartleresponse,butthiseffect wasnotstatisticallysignificant.TheEag1K+channelsantibodybilaterallyinjectedin
Fig.4. EffectsofEag1K+ channelsantibodyinthePPIdisruptioninducedby
apomorphine.Eag1K+channelsantibodybilaterallyinjectedondentategyrusof
hippocampusdidnotmodifythePPI-disruptiveeffectofapomorphine(prepulse intensitiesof73and81dB).*P<0.05comparedwithpost-surgicalcondition.Data representmeans±SEM.RM-ANOVA,posthocDuncan(P<0.05;n=9).
Eag1antibody(0.5gdatanotshown;or1.0g)intothedentate
gyrusdidnotmodifyapomorphine-disruptiveeffectsinthePPI,but reversedthedecreasedstartleamplitudemeasuredaftersurgery.
NophysiologicalfunctionfortheEag1K+channelsinthecentral
nervoussystemhasbeenreportedsofarformammals.Recently,
nodifferenceinthe PPIdisruptioninducedby apomorphine in
Eag1knockoutanimalswasfound,corroboratingwithourresults
[41]. However, these authors demonstrate that Eag1 knockout
mice(Kv10.1−/−) showan increased reactivity to apomorphine
treatmentinthePPItestafteramphetaminesensitization,anda significantincreaseintheresponsivenesstothehaloperidolinthe catalepsytest.TheauthorssuggestedthatKv10.1−/−miceshowa
hyperreactivityofthedopaminergicsystem,oradecreased
den-sity/numberofthedopaminergicreceptors[41].
Itwasimpossibletodisclosethereasonfordecreasingstartle
amplitudeafterthehippocampalcannulaeimplantation.Despite
thefact that startle reflexis sensitiveto habituation, and may
reflect hearing loss, these do not appear the reasons for the
startledecrease.Zhangandco-workersconductedseveralstudies
usinganextensivenumberofdrug-freeratswithdorsalor
ven-tralhippocampal-cannulation[1,44–46],buttheseauthorsdidnot describeanystartlerefleximpairment. Contrasting, ithasbeen reportedtheimpactofdifferentmanipulationsonventralor dor-salhippocampusinthestartlereactivity[45,46].Inaddition,Zhang andco-workers[46]suggestedthattheseeffectsinthestartle
reac-tivitymaybemediatedthroughthehippocampalprojectionsto
theamygdalaortothebednucleusofthestriaterminalis,which haveaccesstothebrainstemstartlecircuit[21].Primary acous-ticstartlepathwayinvolvesfewsynapsesincludingthecochlear rootneurons,neuronsinthenucleusreticularispontiscaudalis,and motoneuronsinthespinalcord[22].Sincethestartlereflexishigh sensitivetohabituation, sensitization,sensorimotor gating, and affectivemodulation,itmightbeusedtostudyseveralconditions includingfear and anxiety, affective disturbances, motivational states,andhomeostasis[13].Undoubtedly,Eag1K+channel
block-adeeffectsinthestartleresponsemeritsfurtherinvestigation. Contrasting,consistentwithSwerdlowandco-workers[35]we shouldcarefullyinterpretingtreatmenteffectsinthePPIresponse inthe presenceof parallel effectson startleamplitude. Consis-tent withtheseauthorsit is possiblethat in thepresence of a reductioninthestartlemagnitudeinpulse-alonetrialsit is
dif-ficulttodeterminewhetherthelackof acomparable reduction
outrobustlyaffectingtheapomorphine-disruptiveeffectsinthe PPI.Weprovidethefirstdemonstrationofthepossibleinfluence ofthesechannelsinthestartleresponse,whichmayrepresenta biologicalimportantphenomenon.Althoughourresultsdonot sup-porttheclassicalantipsychotic-likeeffectstotheEag1K+channels
blockadedatameritsfurtherstudies.
Acknowledgements
WewouldliketothankCéliaAp.daSilvaforthetechnical sup-port,andtoNadiaRubiaFerreira(PhD)whichfriendlygaveusthe
Eag1K+channelsimmunohistochemistryphotomicrographs.This
researchwassupportedbyCNPqBrazilandCAPES/DAAD.
References
[1]T.Bast,W.N.Zhang,C.Heidbreder,J.Feldon,Hyperactivityanddisruptionof prepulseinhibitioninducedbyN-methyl-d-aspartatestimulationoftheventral hippocampusandtheeffectsofpretreatmentwithhaloperidolandclozapine, Neuroscience103(2001)325–335.
[2]D.L.Braff,M.A.Geyer,N.R.Swerdlow,Humanstudiesofprepulseinhibition ofstartle:normalsubjects,patientgroups,andpharmacologicalstudies, Psy-chopharmacology(Berlin)156(2001)234–258.
[3]M.R.Breier,B.Lewis,J.M.Shoemaker,G.A.Light,N.R.Swerdlow,Sensoryand sensorimotorgating-disruptiveeffectsofapomorphineinSpragueDawleyand LongEvansrats,Behav.BrainRes.208(2010)560–565.
[4]J.Brosda,L.Hayn,C.Klein,M.Koch,C.Meyer,R.Schallhorn,N.Wegener, Phar-macologicalandparametricalinvestigationofprepulseinhibitionofstartleand prepulseelicitedreactionsinWistarrats,Pharmacol.Biochem.Behav.99(2011) 22–28.
[5]S.B.Caine,M.A.Geyer,N.R.Swerdlow,Carbacholinfusionintothedentategyrus disruptssensorimotorgatingofstartleintherat,Psychopharmacology(Berlin) 105(1991)347–354.
[6]V.Calderone,L.Testai,E.Martinotti,M.DelTacca,M.C.Breschi,Drug-induced blockofcardiacHERGpotassiumchannelsanddevelopmentoftorsadede pointesarrhythmias:thecaseofantipsychotics,J.Pharm.Pharmacol.57(2005) 151–161.
[7]N.R.Ferreira,M.Mitkovski,W.Stühmer,L.A.Pardo,E.A.DelBel, Ether-à-go-go1(Eag1)potassiumchannelexpressionindopaminergicneuronsofbasal gangliaismodulatedby6-hydroxydopaminelesion,Neurotox.Res.21(2012) 317–333.
[8]R.V.Frolov,A.Bagati,B.Casino,S.Singh,PotassiumchannelsinDrosophila: his-toricalbreakthroughs,significance,andperspectives,J.Neurogenet.26(2012) 275–290.
[9]M.A. Geyer, K. Krebs-Thomson,D.L. Braff, N.R. Swerdlow, Pharmacologi-calstudiesofprepulseinhibitionmodelsofsensorimotorgatingdeficitsin schizophrenia:adecadeinreview,Psychopharmacology(Berlin)156(2001) 117–154.
[10]N.Guo,K.Yoshizaki,R.Kimura,F.Suto,Y.Yanagawa,N.Osumi,Asensitive periodforGABAergicinterneuronsinthedentategyrusinmodulating sensor-imotorgating,J.Neurosci.33(2013)6691–6704.
[11]D.Gómez-Varela,T.Kohl,M.Schmidt,M.E.Rubio,H.Kawabe,R.B.Nehring, S.Schäfer,W.Stühmer,L.A.Pardo,CharacterizationofEag1channellateral mobilityinrathippocampalculturesbysingle-particle-trackingwithquantum dots,PLoSOne5(2010)e8858.
[13]C.Grillon,J.Baas,Areviewofthemodulationofthestartlereflexby affec-tivestatesanditsapplicationinpsychiatry,Clin.Neurophysiol.114(2003) 1557–1579.
[14]P.J.Harrison,Thehippocampusinschizophrenia:areviewofthe neuropatho-logicalevidenceanditspathophysiologicalimplications,Psychopharmacology (Berlin)174(2004)151–162.
[15]O.D.Howes,S.Kapur,Thedopaminehypothesisofschizophrenia:versionIII– thefinalcommonpathway,Schizophr.Bull.35(2009)549–562.
[16]P. Imbrici, D.C. Camerino,D. Tricarico, Major channels involvedin neu-ropsychiatricdisordersandtherapeuticperspectives,Front.Genet.4(2013) 76.
[17]H.T.Ito,E.M.Schuman,Frequency-dependentgatingofsynaptictransmission andplasticitybydopamine,Front.NeuralCircuits1(2007)1.
[18]C.J. Jeng, C.C. Chang, C.Y. Tang, Differential localization of rat Eag1 and Eag2 K+ channels in hippocampal neurons, Neuroreport 16 (2005)
229–233.
[19]M.Ju,D.Wray,Molecularidentificationandcharacterisationofthehumaneag2 potassiumchannel,FEBSLett.524(2002)204–210.
[20]S.Kapur,P.Seeman,Doesfastdissociationfromthedopamined(2)receptor explaintheactionofatypicalantipsychotics?Anewhypothesis,Am.J. Psychi-atry158(2001)360–369.
[21]M.Koch,Theneurobiologyofstartle,Prog.Neurobiol.59(1999)107–128. [22]Y.Lee,D.E.López,E.G.Meloni,M.Davis,Aprimaryacousticstartlepathway:
obligatoryroleofcochlearrootneuronsandthenucleusreticularispontis cau-dalis,J.Neurosci.16(1996)3775–3789.
[23]J.Ludwig,R.Weseloh,C.Karschin,Q.Liu,R.Netzer,B.Engeland,C.Stansfeld, O.Pongs,Cloningandfunctionalexpressionofrateag2,anewmemberofthe ether-à-go-gofamilyofpotassiumchannelsandcomparisonofitsdistribution withthatofeag1,Mol.Cell.Neurosci.16(2000)59–70.
[24]S.Martin,C. Linode Oliveira,F. Mello deQueiroz, L.A. Pardo,W. Stüh-mer,E.DelBel,Eag1potassiumchannelimmunohistochemistryintheCNS ofadultratandselectedregionsofhumanbrain,Neuroscience155(2008) 833–844.
[25]Y.Mu,C.Zhao,F.H.Gage,Dopaminergicmodulationofcorticalinputs dur-ing maturationofadult-borndentategranulecells,J.Neurosci.31(2011) 4113–4123.
[26]T.Occhiodoro,L. Bernheim,J.H.Liu, P.Bijlenga,M.Sinnreich,C.R.Bader, J. Fischer-Lougheed,Cloningofahumanether-à-go-gopotassiumchannel expressedinmyoblastsattheonsetoffusion,FEBSLett.434(1998)177–182. [27]L.A.Pardo,D.delCamino,A.Sánchez,F.Alves,A.Brüggemann,S.Beckh,W. Stüh-mer,OncogenicpotentialofEAGK(+)channels,EMBOJ.18(1999)5540–5547. [28]G.Paxinos,C.Watson,TheRatBraininStereotaxicCoordinates,AcademicPress,
SanDiego,1997.
[29]W. Perry,D. Feifel, A. Minassian,I. Bhattacharjie, D.L.Braff, Information processingdeficitsinacutelypsychoticschizophreniapatientsmedicatedand unmedicatedatthetimeofadmission,Am.J.Psychiatry159(2002)1375–1381. [30]C.Salum,A.C.Issy,M.L.Brandão,F.S.Guimarães,E.A.Bel,Nitricoxidemodulates dopaminergicregulationofprepulseinhibitioninthebasolateralamygdala,J. Psychopharmacol.25(2011)1639–1648.
[31]A.Sharma,H.S.Sharma,Monoclonalantibodiesasnovelneurotherapeutic agentsinCNSinjuryandrepair,Int.Rev.Neurobiol.102(2012)23–45. [32]P.D.Shepard,C.C.Canavier,E.S.Levitan,Ether-à-go-go-relatedgenepotassium
channels:what’sallthebuzzabout?Schizophr.Bull.33(2007)1263–1269.
[33]C.Silveira,J.Marques-Teixeira,A.J.deBastos-Leite,Morethanonecentury ofschizophrenia:anevolvingperspective, J.Nerv. Ment.Dis.200(2012) 1054–1057.
[34]M.K.Stachowiak,A.Kucinski,R.Curl,C.Syposs,Y.Yang,S.Narla,C.Terranova,D. Prokop,I.Klejbor,M.Bencherif,B.Birkaya,T.Corso,A.Parikh,E.S.Tzanakakis,S. Wersinger,E.K.Stachowiak,Schizophrenia:aneurodevelopmentaldisorder– integrativegenomichypothesisandtherapeuticimplicationsfromatransgenic mousemodel,Schizophr.Res.143(2013)367–376.
[35]N.R.Swerdlow,D.L.Braff,M.A.Geyer,Animalmodelsofdeficientsensorimotor gating:whatweknow,whatwethinkweknow,andwhatwehopetoknow soon,Behav.Pharmacol.11(2000)185–204.
[36]N.R.Swerdlow,D.L.Braff,M.A.Geyer,G.F.Koob,Centraldopamine hyperactiv-ityinratsmimicsabnormalacousticstartleresponseinschizophrenics,Biol. Psychiatry21(1986)23–33.
[37]N.R.Swerdlow,D.L.Braff,N.Taaid,M.A.Geyer,Assessingthevalidityofan animalmodelofdeficientsensorimotorgatinginschizophrenicpatients,Arch. Gen.Psychiatry51(1994)139–154.
[38]N.R.Swerdlow,A.Eastvold,B.Karban,Y.Ploum,N.Stephany,M.A.Geyer,K. Cadenhead,P.P.Auerbach,Dopamineagonisteffectsonstartleand sensorimo-torgatinginnormalmalesubjects:timecoursestudies,Psychopharmacology (Berlin)161(2002)189–201.
[39]N.R.Swerdlow,G.A.Light,M.R.Breier,J.M.Shoemaker,R.L.SaintMarie,A.C. Neary,M.A.Geyer,K.E.Stevens,S.B.Powell,Sensoryandsensorimotorgating deficitsafterneonatalventralhippocampallesionsinrats,Dev.Neurosci.34 (2012)240–249.
[40]L.Testai,A.M.Bianucci,I.Massarelli,M.C.Breschi,E.Martinotti,V.Calderone, Torsadogeniccardiotoxicityofantipsychoticdrugs:astructuralfeature, poten-tiallyinvolvedintheinteractionwithcardiacHERGpotassiumchannels,Curr. Med.Chem.11(2004)2691–2706.
[41]R.Ufartes,T.Schneider,L.S.Mortensen,C.deJuanRomero,K.Hentrich,H. Knoetgen,V.Beilinson,W.Moebius,V.Tarabykin,F.Alves,L.A.Pardo,J.N. Rawl-ins,W.Stuehmer,BehaviouralandfunctionalcharacterizationofKv10.1(Eag1) knockoutmice,Hum.Mol.Genet.22(11)(2013)2247–2262.
[42]J.W.Warmke,B.Ganetzky,Afamilyofpotassiumchannelgenesrelatedto eaginDrosophilaandmammals,Proc.Natl.Acad.Sci.U.S.A.91(1994) 3438–3442.
[43]J. Zhang,C. Forkstam, J.A. Engel,L. Svensson,Role of dopaminein pre-pulseinhibitionofacousticstartle,Psychopharmacology(Berlin)149(2000) 181–188.
[44]W.N.Zhang,T.Bast,J.Feldon,EffectsofhippocampalN-methyl-d-aspartate infusiononlocomotoractivityandprepulseinhibition:differencesbetween thedorsalandventralhippocampus,Behav.Neurosci.116(2002)72–84. [45]W.N. Zhang, T. Bast, J. Feldon, Microinfusion of the non-competitive
N-methyl-d-aspartatereceptorantagonistMK-801(dizocilpine)intothe dor-salhippocampusofwistarratsdoesnotaffectlatentinhibitionandprepulse inhibition,butincreasesstartlereactionandlocomotoractivity,Neuroscience 101(2000)589–599.